Invesco Ltd. Atossa Therapeutics, Inc. Transaction History

Invesco Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.28 $27,857 - $41,950	-32,774 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.11 - $1.74 $779 - $1,221	-702 Reduced 2.1%	32,774 $41,000
Q4 2021 Feb 14, 2022	SELL	$1.6 - $3.27 $5,776 - $11,804	-3,610 Reduced 9.73%	33,476 $54,000
Q3 2021 Nov 15, 2021	SELL	$2.89 - $6.4 $5.24 Million - $11.6 Million	-1,814,267 Reduced 98.0%	37,086 $121,000
Q2 2021 Aug 17, 2021	BUY	$1.52 - $8.62 $2.81 Million - $16 Million	1,851,353 New	1,851,353 $11.7 Million

19.3M

95K

82.4K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $147M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.